Takeda Pharmaceutical Co Ltd (TKPHF) EPS (Basic) (2017 - 2026)
Takeda Pharmaceutical (TKPHF) posted quarterly EPS (Basic) of $0.45 for Q2 2026, down 17.09% year-over-year from $0.54 in Q2 2025, and down 10.33% quarter-over-quarter from $0.5 in Q1 2026.
Takeda Pharmaceutical Co Ltd (TKPHF) EPS (Basic) (2017 - 2026) Analysis & Trends
Takeda Pharmaceutical's EPS (Basic) history runs 10 years deep, the most recent figure standing at $0.45 for Q2 2026.
- In Q2 2026, EPS (Basic) fell 17.09% year-over-year to $0.45; the TTM figure through Jun 2026 stood at $0.36 (down 76.1% YoY), while the FY2026 annual figure was -$0.64, down 243.23% from the prior year.
- EPS (Basic) for Q2 2026 stood at $0.45, down from $0.5 in the prior quarter.
- The five-year high for EPS (Basic) was $1.26 in Q3 2023, with the low at -$1.52 in Q4 2025.
- The 5-year median for EPS (Basic) is $0.48 (2026), against an average of $0.35.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) soared 918.32% in 2023, then sank 421.21% in 2024.
- Takeda Pharmaceutical's EPS (Basic) stood at $0.54 in 2022, then sank by 75.28% to $0.13 in 2023, then plunged by 421.21% to -$0.43 in 2024, then sank by 253.81% to -$1.52 in 2025, then jumped by 129.58% to $0.45 in 2026.
- Business Quant data shows TKPHF's EPS (Basic) at $0.45 in Q2 2026, $0.5 in Q1 2026, and -$1.52 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.45 |
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | -1.52 |
| Sep 30, 2025 | 0.93 |
| Jun 30, 2025 | 0.54 |
| Mar 31, 2025 | 0.52 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | 0.90 |
| Jun 30, 2024 | 0.39 |
| Mar 31, 2024 | 0.41 |
| Dec 31, 2023 | 0.13 |
| Sep 30, 2023 | 1.26 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.51 |
| Dec 31, 2022 | 0.54 |
| Sep 30, 2022 | 0.29 |
| Jun 30, 2022 | 0.53 |
| Mar 31, 2022 | -0.06 |
| Dec 31, 2021 | 0.32 |
| Sep 30, 2021 | 0.27 |